vs

Side-by-side financial comparison of EyePoint, Inc. (EYPT) and GREENPOWER MOTOR Co INC. (GP). Click either name above to swap in a different company.

GREENPOWER MOTOR Co INC. is the larger business by last-quarter revenue ($7.2M vs $5.3M, roughly 1.4× EyePoint, Inc.). GREENPOWER MOTOR Co INC. runs the higher net margin — -65.6% vs -1114.3%, a 1048.7% gap on every dollar of revenue. On growth, GREENPOWER MOTOR Co INC. posted the faster year-over-year revenue change (-11.5% vs -43.7%).

EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.

GreenPower Motor Company Inc. is a Canadian electric bus manufacturer and distributor in North America. The company fabricates multiple zero-emission models, including transit buses, school buses, and double decker buses. GreenPower headquarters are in Vancouver, British Columbia, with a sales office in Rancho Cucamonga, California; an assembly facility in Porterville, California; and a production facility in South Charleston, West Virginia. Its stock is traded on Nasdaq the United States.

EYPT vs GP — Head-to-Head

Bigger by revenue
GP
GP
1.4× larger
GP
$7.2M
$5.3M
EYPT
Growing faster (revenue YoY)
GP
GP
+32.2% gap
GP
-11.5%
-43.7%
EYPT
Higher net margin
GP
GP
1048.7% more per $
GP
-65.6%
-1114.3%
EYPT

Income Statement — Q2 FY2025 vs Q3 FY2025

Metric
EYPT
EYPT
GP
GP
Revenue
$5.3M
$7.2M
Net Profit
$-59.4M
$-4.7M
Gross Margin
14.6%
Operating Margin
-1166.8%
Net Margin
-1114.3%
-65.6%
Revenue YoY
-43.7%
-11.5%
Net Profit YoY
-92.8%
-2.1%
EPS (diluted)
$-0.85
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EYPT
EYPT
GP
GP
Q2 25
$5.3M
Q1 25
$24.5M
Q4 24
$11.6M
$7.2M
Q3 24
$10.5M
$5.3M
Q2 24
$9.5M
$3.0M
Q1 24
$11.7M
Q4 23
$14.0M
$8.2M
Q3 23
$15.2M
$8.4M
Net Profit
EYPT
EYPT
GP
GP
Q2 25
$-59.4M
Q1 25
$-45.2M
Q4 24
$-41.4M
$-4.7M
Q3 24
$-29.4M
$-4.7M
Q2 24
$-30.8M
$-5.4M
Q1 24
$-29.3M
Q4 23
$-14.1M
$-4.6M
Q3 23
$-12.6M
$-4.3M
Gross Margin
EYPT
EYPT
GP
GP
Q2 25
Q1 25
Q4 24
14.6%
Q3 24
93.0%
8.6%
Q2 24
85.2%
7.4%
Q1 24
93.5%
Q4 23
16.6%
Q3 23
92.1%
14.6%
Operating Margin
EYPT
EYPT
GP
GP
Q2 25
-1166.8%
Q1 25
-199.7%
Q4 24
-390.4%
Q3 24
-311.2%
Q2 24
-364.5%
Q1 24
-285.2%
Q4 23
-116.6%
Q3 23
-94.7%
Net Margin
EYPT
EYPT
GP
GP
Q2 25
-1114.3%
Q1 25
-184.8%
Q4 24
-357.3%
-65.6%
Q3 24
-279.0%
-87.9%
Q2 24
-325.3%
-179.8%
Q1 24
-250.6%
Q4 23
-100.5%
-56.9%
Q3 23
-83.0%
-50.4%
EPS (diluted)
EYPT
EYPT
GP
GP
Q2 25
$-0.85
Q1 25
$-0.65
Q4 24
$-0.65
$-0.17
Q3 24
$-0.54
$-0.18
Q2 24
$-0.58
$-0.21
Q1 24
$-0.55
Q4 23
$-0.32
$-0.19
Q3 23
$-0.33
$-0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EYPT
EYPT
GP
GP
Cash + ST InvestmentsLiquidity on hand
$255.7M
$621.1K
Total DebtLower is stronger
Stockholders' EquityBook value
$246.0M
$2.1M
Total Assets
$301.1M
$37.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EYPT
EYPT
GP
GP
Q2 25
$255.7M
Q1 25
$318.2M
Q4 24
$370.9M
$621.1K
Q3 24
$253.8M
$116.9K
Q2 24
$280.2M
$528.3K
Q1 24
$299.3M
Q4 23
$331.1M
$4.0M
Q3 23
$136.0M
$2.0M
Stockholders' Equity
EYPT
EYPT
GP
GP
Q2 25
$246.0M
Q1 25
$298.4M
Q4 24
$336.5M
$2.1M
Q3 24
$218.7M
$4.2M
Q2 24
$228.3M
$8.6M
Q1 24
$249.9M
Q4 23
$266.3M
$18.1M
Q3 23
$58.6M
$22.3M
Total Assets
EYPT
EYPT
GP
GP
Q2 25
$301.1M
Q1 25
$362.6M
Q4 24
$418.5M
$37.4M
Q3 24
$300.9M
$39.4M
Q2 24
$324.2M
$43.5M
Q1 24
$329.2M
Q4 23
$355.2M
$50.2M
Q3 23
$160.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EYPT
EYPT
GP
GP
Operating Cash FlowLast quarter
$-62.6M
$-1.1M
Free Cash FlowOCF − Capex
$-63.8M
FCF MarginFCF / Revenue
-1196.5%
Capex IntensityCapex / Revenue
22.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-194.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EYPT
EYPT
GP
GP
Q2 25
$-62.6M
Q1 25
$-53.1M
Q4 24
$-35.8M
$-1.1M
Q3 24
$-39.0M
$-1.3M
Q2 24
$-20.2M
$-3.2M
Q1 24
$-31.2M
Q4 23
$-23.1M
$1.4M
Q3 23
$-15.2M
$-5.4M
Free Cash Flow
EYPT
EYPT
GP
GP
Q2 25
$-63.8M
Q1 25
$-53.4M
Q4 24
$-36.2M
Q3 24
$-40.6M
Q2 24
$-21.1M
Q1 24
$-32.4M
Q4 23
$-24.0M
Q3 23
$-16.9M
FCF Margin
EYPT
EYPT
GP
GP
Q2 25
-1196.5%
Q1 25
-218.4%
Q4 24
-312.7%
Q3 24
-385.8%
Q2 24
-222.4%
Q1 24
-277.0%
Q4 23
-171.0%
Q3 23
-111.3%
Capex Intensity
EYPT
EYPT
GP
GP
Q2 25
22.9%
Q1 25
1.1%
Q4 24
3.3%
Q3 24
15.0%
Q2 24
9.5%
Q1 24
10.2%
Q4 23
6.3%
Q3 23
11.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons